WithdrawnNot Applicable

A COPD Data Registry for Participants With Frequent Exacerbations

Stopped: The study was withdrawn due to a business decision.

0Started 2026-09-14

Plain-language summary

This registry will collect data on COPD, including the course of disease, treatment patterns, and potential new therapies. The registry will also track the experience of participants and caregivers in clinical practice.

Who can participate

Age range

40 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of COPD for at least 12 months * On stable, standard of care (SoC) COPD maintenance therapy * Have experienced at least 2 exacerbations (moderate or severe) in the last 12 months, with one of them occurring while on SoC therapy Exclusion Criteria: * In palliative treatment * Participating in any interventional drug trials

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Disease course of participants enrolled in COPD registry

Timeframe: Up to 3 years

Treatment patterns of participants enrolled in COPD registry

Timeframe: Up to 3 years

Number of novel therapies for participants enrolled in COPD registry

Timeframe: Up to 3 years

Health care utilization (HCU) by participants enrolled in COPD registry as measured by number of medical visits

Timeframe: Up to 3 years

HCU by participants enrolled in COPD registry as measured by types of medical care institutions visited

Timeframe: Up to 3 years

Quality of life (QoL) of participants enrolled in COPD registry as measured by the Chronic Airways Assessment Test (CAAT)

Timeframe: Up to 3 years

QoL of participants enrolled in COPD registry as measured by the EQ-5D Five Levels plus respiratory dimension (EQ-5D-5L+R) questionnaire

Trial details

NCT IDNCT07059273

SponsorHoffmann-La Roche

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2031-05-01

View on ClinicalTrials.gov More COPD trials

Who can participate

Age range

40 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Disease course of participants enrolled in COPD registry

Timeframe: Up to 3 years

Treatment patterns of participants enrolled in COPD registry

Timeframe: Up to 3 years

Number of novel therapies for participants enrolled in COPD registry

Timeframe: Up to 3 years

Health care utilization (HCU) by participants enrolled in COPD registry as measured by number of medical visits

Timeframe: Up to 3 years

HCU by participants enrolled in COPD registry as measured by types of medical care institutions visited

Timeframe: Up to 3 years

Quality of life (QoL) of participants enrolled in COPD registry as measured by the Chronic Airways Assessment Test (CAAT)

Timeframe: Up to 3 years

QoL of participants enrolled in COPD registry as measured by the EQ-5D Five Levels plus respiratory dimension (EQ-5D-5L+R) questionnaire